Apparently normal mitral valves in patients with heart failure demonstrate biochemical and structural derangements An extracellular matrix and echocardiographic study by Grande-Allen, K. Jane et al.
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pparently Normal Mitral Valves in
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iochemical and Structural Derangements
n Extracellular Matrix and Echocardiographic Study
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OBJECTIVES This study assessed apparently normal mitral valves from patients with congestive heart failure
(CHF) using biochemical and echocardiographic measures of extracellular matrix (ECM) and
anatomy.
BACKGROUND Mitral regurgitation (MR) is frequently found in patients with CHF. This MR is considered
purely functional, yet animal studies suggest that altered left ventricular (LV) function leads
to increased cellularity and fibrosis of the mitral valve. Therefore, we hypothesized that
patients with CHF might have partly organic MR, via dysfunctional valvular remodeling.
METHODS Mitral valves from transplant recipient hearts of patients with CHF (23 dilated, 14 ischemic)
were analyzed for deoxyribonucleic acid (DNA), collagen, glycosaminoglycan (GAG), and
water concentrations and compared with autopsy controls. Cardiac dimensions and functional
parameters (measured from recent echocardiograms) were compared with biochemical
parameters using a repeated measures generalized linear model.
RESULTS The mitral valves in CHF had up to 78% more DNA (p 0.03), 59% more GAGs (p 0.02),
and 15% more collagen (p  0.007), but 7% less water (p  0.05) than normal. The absence of
anterior leaflet redundancy was associated with these deranged biochemical measures (p  0.03).
Associations were found between leaflet thickness and DNA concentration (, p  0.003),
annular diameter and chordal collagen (, p 0.03), and water concentration and both left atrial
diameter (, p  0.008) and LV collagen concentration (, p  0.04).
CONCLUSIONS Mitral valves in CHF are biochemically different from normal, with ECM changes that are
influenced by the altered cardiac dimensions. This remodeling suggests that MR in patients
with CHF may not be purely functional, and that these valves are not “normal.” (J Am Coll
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.06.079Cardiol 2005;45:54–61) © 2005 by the American College of Cardiology Foundation
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titral regurgitation (MR) is present in more than half of all
atients with ischemic or idiopathic dilated cardiomyopathy
DCM) resulting in congestive heart failure (CHF) (1,2).
See page 62
ecause the mitral valve in these patients often appears
ormal on echocardiographic or gross pathologic examina-
ion, this MR is generally considered to be a functional
onsequence of alterations in the cardiac geometry. In
unctional MR, dilation of the ventricle and annulus or
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ccepted May 11, 2004.bnormal wall motion resulting from an ischemic event
istorts the geometry of the mitral valve and alters its
ormal loading patterns, which then produces MR (3,4).
rolonged alteration to the normal valvular loading pat-
erns, however, has been shown to up-regulate procollagen,
ollagen, and deoxyribonucleic acid (DNA) synthesis within
itral valve leaflets of animal models (5–7). Thus, it appears
ikely that MR may begin as purely functional but may be
ubsequently linked to microstructural changes or dysfunc-
ional “remodeling” of the valve tissues. We hypothesize
hat mitral valves from patients with CHF will demonstrate
his dysfunctional remodeling, and that the biochemical
hanges in the valvular extracellular matrix (ECM) are
elated to the cardiac distortion and dysfunction resulting
rom CHF. Therefore, the objectives of this study were first
o quantify the ECM changes in mitral valve tissues from
atients with CHF relative to normal control subjects, and
hen to examine the relationships between the matrix and
ardiac and valvular dimensions and function.
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ubjects. The study subjects consisted of 37 patients with
F who received a heart transplant between September
998 and August 2001 (Table 1). These patients were
reviously diagnosed with CHF on the basis of severe left
entricular (LV) systolic dysfunction (ejection fraction
25%) and either severe LV dilation or a history of
therosclerosis, coronary artery disease, or myocardial in-
arction. Ischemic cardiomyopathy (ICM) (n  14) was
istinguished from DCM (n  23) on the basis of the
resence of segmental wall motion abnormalities and the
resence of significant obstructive coronary disease. Echo-
ardiograms that adequately demonstrated the cardiac ge-
metry (transthoracic) and the mitral valve (transesopha-
eal) were available for many of these patients (Table 1).
atients who had mitral valve surgery before transplantation
ere excluded from the study. The research use of these
atient tissues was approved by the Cleveland Clinic Foun-
ation Institutional Review Board.
There were separate normal control groups for the
ifferent components of the study; in each component the
ontrol group matched the mean age and gender propor-
ions of the patient group (Table 1). For the biochemical
omparisons, both groups were predominantly men (CHF
roup 73% vs. control group 68%) and of similar age (CHF
roup 56  14 years vs. controls group 50  13 years). The
iochemical control group consisted of normal control
itral valves obtained from autopsies of persons who died of
auses other than cardiovascular/cardiac disease or sudden
eath; cadavers were stored at 4°C for24 h before autopsy.
Abbreviations and Acronyms
CHF  congestive heart failure
DCM dilated cardiomyopathy
DNA  deoxyribonucleic acid
ECM  extracellular matrix
GAG  glycosaminoglycan
ICM  ischemic cardiomyopathy
LV  left ventricular
MR  mitral regurgitation
TEE  transesophageal echocardiography
TTE  transthoracic echocardiography
able 1. Subject Characteristics
Group Subjects
Gender
(F/M)
Age
(yrs)
iochemistry
Controls 25 17/8 50 1
Transplants 37 27/10 56 1
ransthoracic echocardiography
Controls 8 6/2 57 8
Transplants 33 25/8 57 1
ransesophageal echocardiography
Controls 7 6/1 57 6
Transplants 11 10/1 57 7CM  dilated cardiomyopathy; ICM  ischemic cardiomyopathy.ecause valve tissues kept at 4°C retain their matrix-based
echanical properties for up to five days (8), we believe that
he ECM in these cadaveric valves was not measurably
egraded postmortem. Because echocardiograms were not
vailable for these autopsy subjects, separate control groups
ere constructed for the anatomic and functional compar-
sons. The transthoracic echocardiogram (TTE) group con-
isted of patients 57  12 years old (vs. 57  8 years for
ontrol group) with 76% male patients (vs. 75%). Likewise,
he transesophageal echocardiogram (TEE) group of pa-
ients had a mean age of 57  7 years (vs. 57  6 years for
ontrol group) with 91% male patients (vs. 86%). The TTE
nd TEE control groups (Table 1) were selected retroac-
ively from a database of patients who underwent echocar-
iography between July 2002 and June 2003 and who did
ot demonstrate any cardiac or valvular disease.
pecimen preparation. The transplant recipient hearts
ere obtained immediately after transplantation and patho-
ogic inspection. The mitral valve was dissected free and
rimmed into leaflet and chordal specimens. The anterior
eaflets were divided into the free edge (rough zone) and
entral region (clear zone). The posterior leaflet was not
ubdivided. The chordae were subdivided by insertion into
ither the posterior or anterior leaflet, in either the basal or
arginal position. All the chordae from each group were
ooled to obtain sufficient sample mass. In addition, a
00-mg section of the recipient heart left ventricle was
eserved to measure LV collagen concentration.
iochemical assays. The wet weights were determined,
nd water concentration was measured by lyophilizing the
amples for 16 h and then weighing again when dry. To
olubilize the tissues, each sample was minced, placed in 1
l of 100 mM ammonium acetate (pH 7), and incubated
ith 100 l of proteinase-K (10 mg/ml) at 60°C for 16 h as
reviously described (9). The solubilized samples were then
eated at 100°C for 10 min to inactivate the proteinase-K,
nd 100-l aliquots were taken to measure the hydroxypro-
ine (for collagen), DNA (for cellularity), and hexuronic acid
oncentration (for glycosaminoglycans [GAGs]) (9). The
easured values from each sample were divided by the
ample dry weights to obtain normalized concentrations.
Diagnosis
(DCM/ICM)
Total Number of Specimens Analyzed
Anterior Leaflet Posterior Leaflet Chordae
— 44 23 74
23/14 47 34 79
—
20/13
—
6/53
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Valvular Matrix Remodeling in Heart Failure January 4, 2005:54–61ry weight was chosen as the normalizing criteria to avoid
ossible confounding by changes in water concentration.
chocardiographic analysis. Cardiac and valvular anat-
my and function were retroactively analyzed from the
atients’ clinical echocardiograms when available. Left ven-
ricular and atrial parameters were analyzed using TTEs
taken, on average, 70 days before transplant). The LV
olumes and ejection fraction were measured using the
odified Simpson’s method (10). The LV dimensions—
iameters, septal and posterior wall thickness—were mea-
ured by standard M-mode techniques (11). Left atrial
imensions were measured using validated techniques
12,13). Mitral annular diameter was measured in the
our-chamber and two-chamber views (14). Two-
imensional TEEs (taken immediately before transplant)
ere analyzed to describe mitral valve geometry and func-
ion. In the long-axis view, the length of the leaflets was
easured from annulus to leaflet tip with the leaflets open
n diastole. Leaflet thickness was measured at the leaflet tip,
iddle, and base in diastole in the long-axis view. The
egree of MR was assessed semiquantitatively by the size of
he regurgitant jet (15). The presence or absence of leaflet
edundancy—presence characterized by excess leaflet tissue
agging into the atrium (14)—was evaluated in the paraster-
al long-axis view.
tatistical analysis. Descriptive statistics were presented as
ean values and standard deviations for continuous vari-
bles and as frequencies and percentages for categorical data
SAS version 8.2, Cary, North Carolina). Groups were
ompared using standard t tests and chi-square tests. Be-
ause of the many statistical tests, two-tailed significance
as accepted at p 0.01. Slight differences (p 0.05) were
lso reported. To account for multiple measurements from
he same valve, mixed model repeated measures analyses
ere performed using SAS PROC MIXED. Many variance
omponent structures were considered, and compound sym-
etry was assumed in the final models after analyzing
kaike Information Criterion and other selection criteria.
ndependent variable transformations were tested to im-
rove model fit and to ensure that the relation of the
ariable was well calibrated with outcome.
Mixed linear models for each of the biochemical param-
ters investigated differences between the control subjects
nd patients with CHF and within the CHF diagnostic
ubgroups of ICM and DCM. Differences in biochemical
roperties were analyzed between anatomic subgroups
ithin the valve: posterior leaflet, anterior leaflet, and
hordae; center and free edge of the anterior leaflet; basal
nd marginal chordae; and anteriorly and posteriorly insert-
ng chordae.
Interrelations between the echocardiographically mea-
ured parameters were analyzed using univariate correla-
ions. To determine if the concentrations of matrix compo-
ents were related to the alterations in cardiac geometry and
unction, the echocardiographically measured parameters
ere also analyzed with respect to biochemical parameters. hsing repeated measures mixed linear models, univariate
ssociations were investigated for each echocardiographic
easure separately to utilize information from the maxi-
um number of data points. Thereafter, multivariate mixed
inear models were constructed to determine the most
mportant correlates of the biochemical parameters. A
riterion of p  0.05 was used for retention of variables in
he final multivariate models. Unadjusted and adjusted p
alues were provided.
ESULTS
iochemical matrix measurements. The DNA concentra-
ions of the valves from patients with CHF—especially with
CM—were far greater than normal (Figs. 1A and 2A).
his result was most prominent in posterior leaflets (p 
.0025). Likewise, anterior leaflets from patients with CHF
ontained more DNA per tissue dry weight than controls
p  0.0008). The free edge of the anterior leaflet showed
he same trend in DNA (p  0.0001), as did the chordae
nserting anteriorly (p  0.031), but the central region of
he anterior leaflet had only slightly higher DNA concen-
rations (p  0.011). For patients with DCM, the DNA
oncentration for all chordae was slightly higher than
ormal (p  0.033).
The collagen concentrations in the anterior leaflets from
atients with CHF were greater than in normal anterior
eaflets (p  0.007). This difference was also found in the
nterior leaflet free edge (p  0.0035) (Figs. 1B and 2B).
here were no significant differences between collagen
oncentrations in the posterior leaflet and chordal groups as
ompared with the normal control subjects.
Valves from patients with CHF had significantly higher
AG concentrations, which were again most prominent in
atients with DCM (Figs. 1C and 2C). The posterior
eaflets contained more GAGs per dry weight (p  0.021)
han normal posterior leaflets. Likewise, the chordae insert-
ng into the posterior leaflet had significantly higher GAG
oncentrations for patients with DCM (p  0.0037), who
lso had slightly higher GAG concentrations in anterior
hordae (p  0.02).
The increased concentrations of cells and matrix of these
HF valves were accompanied by slightly lower water
oncentrations than in control valves (p  0.046 for
hordae) (Figs. 1D and 2D). Greater reductions in water
oncentration, however, were found in the valves of patients
ith ICM (p  0.04 for posterior leaflets, p  0.0034 for
nterior chordae, p  0.007 for posterior chordae).
Overall, there were no significant differences in biochemical
easures between valves from ICM and DCM patients. Both
roups demonstrated very similar trends when compared with
he normal control groups (Fig. 2). In general, however, the
alves from patients with DCM tended to demonstrate more
ronounced elevations in DNA, collagen, and GAG concen-
ration, whereas the valves from patients with ICM tended to
ave the lowest water concentration.
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January 4, 2005:54–61 Valvular Matrix Remodeling in Heart Failureemographic and echocardiographic measures. There
ere no significant differences in the mean ages of the patient
roup and the autopsy control group (Table 1). Gender
istributions were also identical. In the primary (biochemical)
nalysis groups, the mean age of the DCM group was slightly
ess than ICM (52  16 vs. 62  7, p  0.037), with slightly
ewer male subjects (61% vs. 93%, p  0.034).
The patients demonstrated the classic characteristics of
eart failure (16), but also notably had moderate MR,
nnular dilation, and mitral leaflets that were 26% thicker (p
0.011) and 28% to 41% longer (p  0.002) than normal
Table 2). Leaflet length was significantly correlated with
eft atrial area (anterior: r  0.65, p  0.007; posterior: r 
.71, p  0.014) and annular diameter (posterior: r  0.7,
 0.001), whereas leaflet thickness was correlated with
nnular diameter (anterior: r  0.53; posterior: r  0.66;
oth p  0.027), LV end-diastolic volume (anterior: r 
.64, p  0.05; posterior: r  0.82, p  0.006), and left
trial volume (anterior: r  0.72, p  0.025; posterior: r 
.70, p  0.05). The mechanism of MR in most patients
as the result of annular dilation and/or leaflet restriction.
he LV collagen concentrations were five times higher than
ormal, indicative of ventricular fibrosis. These geometric
nd functional characteristics were similar between patients
igure 1. The extracellular matrix concentrations in control (white bars) an
cid (DNA), (b) collagen, (c) glycosaminoglycan (GAG), (d) water. Theith DCM or ICM, except for left atrial area, which was alightly higher in patients with DCM (p  0.03), and MR
rade, in which patients with DCM were more likely to
ave an MR grade of 3 or 4 (p  0.01). There were no
ignificant differences in LV dimensions between the DCM
nd ICM subgroups (LV internal diastolic diameter 7.5 
.9 DCM group vs. 7.2  0.7 ICM group, p  0.38).
tatistical association analysis. There were numerous sig-
ificant univariate associations between ECM concentra-
ions and the echocardiographically measured parameters.
any of these associations, predominantly related to leaflet
nd annular dimensions, remained significant in the ad-
usted multivariate models (Table 3). The absence of ante-
ior leaflet redundancy, in particular, was associated with
lmost all measures of ECM (Fig. 3). Significant positive
ssociations were also found between anterior leaflet thick-
ess and leaflet DNA, and mitral annular diameter and
hordal collagen. Water was inversely associated with both
eft atrial diameter (leaflets) and LV collagen (chordae). The
rade of MR, expected to be highly associated with the valve
imensions, showed a significant positive association with
eaflet DNA (p  0.01) and a slight positive association
ith chordal collagen (p  0.07) in univariate models, but
hese associations were not significant in the multivariate
gestive heart failure (CHF) (black bars) mitral valves: (a) deoxyribonucleic
es indicate difference versus control valves.nalysis (p  0.6 for both).
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Valvular Matrix Remodeling in Heart Failure January 4, 2005:54–61ISCUSSION
n this study, we have demonstrated that the ECM constit-
ents of mitral valves from patients with end-stage CHF
xhibit fibrotic changes and are substantially different from
hose of age-matched normal control subjects. Moreover,
his dysfunctional remodeling of mitral valves occurs in
roportion to the significant alterations in ventricular, atrial,
nnular, and valvular dimensions that accompany CHF.
hese findings suggest that loading conditions contribute to
atrix remodeling, and that the functional MR that devel-
ps secondary to ICM or DCM is associated with distinc-
ive and abnormal structural changes in the valves.
The altered proportions of ECM, particularly collagen, in
hese mitral valves from patients with CHF indicate that the
issue has become heavily fibrotic. This fibrosis may repre-
ent a tissue adaptation to provide additional tensile
trength (7,17), particularly in patients with CHF, who
ave higher than normal plasma and ventricular levels of
roteolytic enzymes (18) and disruptions of the normal
enin-angiotensin system (19). The excess GAGs in these
issues may also be related to fibrosis, because certain
AGs, via their association with proteoglycans, have roles
igure 2. Significant or slight differences in extracellular matrix concentrati
nd/or ischemic cardiomyopathy (ICM) (checkered bars) groups (diagnost
ollagen, (c) glycosaminoglycan (GAG), (d) water. The p values indicaten collagen fibril organization (9). The dramatically higher soncentration of DNA in these valves (more cells than
ormal per gram of tissue dry mass) may be a result of either
levated cell proliferation or reduced cell turnover or apo-
tosis. These additional cells may be responsible for the
ltered matrix proportions, although determining how their
roduction of ECM has been altered will require more
xperimental, mechanistic studies. Finally, the gains in
ollagen, GAGs, and cell concentrations were accompanied
y a reduction in the concentration of water, consistent with
he definition of fibrotic tissue as being very dense (17).
These biochemical alterations in the valve tissue provide
vidence that the mitral valves have remodeled in these
atients, potentially as an adaptive response to loading or
eometry outside of their normal range. Our findings of
levated collagen and DNA concentrations are supported by
everal previous animal studies. In sheep models of ischemic
eart failure, ischemia of the left ventricle and/or papillary
uscles caused long-term MR and up-regulation of leaflet
rocollagen (collagen precursor) and alterations to the
ormal distribution of leaflet collagen (5,6). Likewise,
ncreasing the mitral valve loads in a rat model of LV
ressure overload caused up-regulated DNA and collagen
etween control (white bars), dilated cardiomyopathy (DCM) (lined bars),
groups for congestive heart failure): (a) deoxyribonucleic acid (DNA), (b)
nce versus control group.ons bynthesis (7).
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January 4, 2005:54–61 Valvular Matrix Remodeling in Heart FailureThe significant associations between the valvular ECM
nd the altered valvular and cardiac dimensions lend further
upport to our hypothesis. Many of these cardiac parameters
emonstrate the dilation of the mitral annulus. In particular,
he absence of anterior leaflet redundancy was a frequent
redictor of remodeling (Fig. 3) consistent with stretching
f the valve tissue across the enlarged annulus. Other
arameters, such as MR severity, that relate to annular
ilation, were associated with the cellular and matrix data in
nivariate models (although MR was not significant [p 
.6] in the adjusted multivariate model).
In DCM or ICM, MR may be induced by annular
ilation, abnormal ventricular wall motion and geometry, or
apillary muscle displacement and subsequent reorientation
f the chordae (3,4,20). Such sustained changes in the valve
nvironment and loading, however, likely also contribute to
he tissue fibrosis found in this study. We propose that the
nnular and subvalvular dilation causes the leaflet to become
ore stretched than normal across the mitral orifice, result-
ng in a loss of coaptation (21,22) (Fig. 4). This leaflet
xtension and stretching applies high tensile and membrane
oads to the posterior leaflet and the free edge of the anterior
eaflet, which are regions of the valve that would normally
xperience compressive stress relief during leaflet coapta-
ion. Correspondingly, these regions exhibited greater mag-
itude changes in tissue composition than the chordae and
he center of the anterior leaflet, which normally experience
igh tensile loads. This regionally specific remodeling is
ikely heavily influenced by regional changes in mechanical
oading; high levels of circulating proteolytic enzymes,
eurohormones, and cytokines may also induce fibrosis but
Table 2. Valvular and Cardiac Chamber Dime
Measurement Subjects
AL length (cm) 19
AL thickness (mm)* 14
PL length (cm)* 18
PL thickness (mm)* 11
MV annular diameter (4C) (cm) 26
LVISD (cm) 32
LVIDD (cm) 32
IVS thickness (cm) 31
PW thickness (cm) 31
LA diameter (cm) 32
LA area (cm2)† 23
LA volume (4C) (cm3) 21
MR, graded 0–4‡ 36
EF (%) 33
LVESV (cm3) 24
LVEDV (cm3) 24
LV collagen (mg/g dry weight) 35
*The leaflets were inadequately imaged to determine measure
subjects with DCM was greater than in ICM (p  0.03). ‡T
 0.01). §Control LV collagen values are from unpublished
4C four-chamber; AL anterior leaflet; CHF conge
fraction; ICM  ischemic cardiomyopathy; IVS  intraventr
left ventricular end-diastolic volume; LVESV left ventricul
diameter; LVISD  left ventricular internal systolic diamete
leaflet; PW  posterior wall.ould presumably affect all regions of the valve equally. In
4
any case, the resulting fibrotic remodeling may affect the
eaflet and chordal material behavior and cause organic
mpedance of normal valve function. It is therefore conceiv-
ble that patients with end-stage CHF have a combination
f organic and functional MR (Fig. 4). However, the
elative contribution of matrix change to the development of
R in patients with heart failure is difficult to determine
nd may be better addressed in a long-term animal model
6).
These findings of larger and thicker than normal mitral
alves in patients with CHF have only been rarely discussed
n published reports (23), nor were they noted in our
atients’ echocardiographic reports, perhaps because the
alves appeared normal in proportion to the enlarged hearts.
urthermore, the altered matrix and structure in these valves
aise questions regarding the surgical repair of these valves
2,24). Although surgical repair is accomplished successfully
s and Functional Parameters
CHF Controls
p Value
(t Test)
3.22 0.49 2.51  0.31 0.001
2.69 0.77 2.13  0.13 0.006
2.31 0.50 1.64  0.23 0.002
2.75 0.68 2.19  0.17 0.01
4.34 0.74 3.75  0.42 0.01
6.77 0.91 3.25  0.42  0.001
7.38 0.87 4.94  0.55  0.001
0.84 0.20 0.98  0.15 0.11
0.87 0.28 0.94  0.11 0.5
5.08 0.89 3.74  0.60  0.001
27.3 5.41 18.1  4.22  0.001
87.0 28.0 46.3  14.3  0.001
2.53 0.99 0.43  0.38  0.001
17 6 57  5  0.001
253 82 60  13  0.001
311 94 129  53  0.001
51.3 27.5 10.2  1.0§  0.001
in some transesophageal echocardiograms. †The LA area in
ere more MR grades 3 and 4 in the subjects with DCM (p
(N.D. and C.M.).
eart failure; DCM dilated cardiomyopathy; EF ejection
septum; LA  left atrial; LV  left ventricular; LVEDV 
-systolic volume; LVIDD left ventricular internal diastolic
 mitral regurgitation; MV  mitral valve; PL  posterior
able 3. P Values From Adjusted Multivariate Association
odels
Biochemical
Measure Cardiac Measure
Association
Direction Leaflets Chordae
NA AL thickness  0.003 —
AL redundancy  0.02 —
LVIDD  — 0.05
AGs AL redundancy  0.02 0.03
ollagen AL redundancy  0.002 —
Mitral annulus (4C)  — 0.03
ater AL redundancy  0.01 —
LA diameter  0.008 —
LVIDD  0.02 —
LV collagen  — 0.04nsion
ments
here w
data
stive h
icular
ar endC  four-chamber; AL  anterior leaflet; GAGs  glycosaminoglycans; LA  left
trial; LV  left ventricular; LVIDD  left ventricular internal diastolic diameter.
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Valvular Matrix Remodeling in Heart Failure January 4, 2005:54–61n both ICM and DCM, the long-term results are often
isappointing, with recurrent regurgitation especially in
atients with ICM. Although long-term failure of ischemic
R repair likely relates to an inadequate correction of the
tructural problem, it is also conceivable that matrix remod-
ling in the valve structure also contributes.
These findings of abnormalities in mitral valves from
ailing hearts also have widespread implications in unrelated
tudies of heart valve disease. Because these valves have been
escribed as “normal” in appearance after gross or echocar-
iographic inspection, valves from failing hearts have served
s normal or control tissues for studies of myxomatous
itral valve disease (17) and valve matrix metalloproteinases
25), and these have been utilized as a source of normal
uman cells for characterization of normal valvular intersti-
igure 3. The extracellular matrix data segregated according to absence or
resence of normal anterior leaflet redundancy. GAGs glycosaminoglycans.ial cells (26). Our findings, however, would suggest caution vn the use of these valves as normal control tissue for other
tudies.
imitations. There are some limitations to how data from
his study may be interpreted. First, these biochemical
easures cannot provide any information about how the
nternal collagenous matrix microstructure of the tissue, or
he valvular interstitial cell phenotype, was affected. For this
eason, we have incorporated histologic and immunohisto-
hemical analyses into our ongoing investigation of this
alve dysfunction. Second, leaflet thicknesses were measured
sing echocardiograms, which have image resolution limits,
s opposed to being directly measured from the tissues.
owever, TEEs are the method of choice for measuring
eaflet thickness in living subjects, and the TEEs from all
atients and control subjects were analyzed identically.
hird, more quantitative measures of MR severity, such as
egurgitant jet dimensions, might have retained significant
ssociations in the multivariate models. Fourth, it was
ntriguing that DCM valves demonstrated greater elevations
n collagen and GAG content, whereas the ICM valves
howed more reduction in water. These biochemical differ-
nces between the DCM and ICM groups, however, were
ot statistically significant, and both groups demonstrated
he same overall trends. The finding that these two CHF
tiologies do not have significant distinctions in their
alvular matrix suggests that valvular remodeling is influ-
nced less by the original etiology and more by the degree of
ardiac remodeling found in these patients with end-stage
HF.
onclusions. In conclusion, these data demonstrate that
uman mitral valves remodel in response to and in propor-
ion to changes in their functional environment. Mitral
igure 4. Proposed mechanism for secondary valvular remodeling.
AGs  glycosaminoglycans; MR  mitral regurgitation.alves in patients with CHF are distinctly different from
t
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R in these patients may not be purely functional.
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